Tytuł pozycji:
ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer
-
Tytuł:
-
ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer
-
Autorzy:
-
Crabb, Simon J.
Birtle, Alison J.
Martin, Karen
Downs, Nichola
Ratcliffe, Ian
Maishman, Tom
Ellis, Mary
Griffiths, Gareth
Thompson, StuartAff3, Aff4
Ksiazek, Lidia
Khoo, Vincent
Jones, Robert J.
-
Źródło:
-
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 35(5):599-607
-